Name (Synonyms) | Correlation | |
---|---|---|
drug1021 | Placebo Administration Wiki | 1.00 |
drug163 | Baricitinib Wiki | 0.45 |
drug591 | Hydroxychloroquine Wiki | 0.11 |
drug1016 | Placebo Wiki | 0.08 |
Name (Synonyms) | Correlation | |
---|---|---|
D055370 | Lung Injury NIH | 0.23 |
D055371 | Acute Lung Injury NIH | 0.12 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.10 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
A randomized, double-blind, placebo-controlled Phase 2/3 study to evaluate the safety and efficacy of DSTAT in patients with Acute Lung Injury (ALI) due to COVID-19. This study is designed to determine if DSTAT can accelerate recovery and prevent progression to mechanical ventilation in patients severely affected by COVID-19.
Description: Alive and free of invasive mechanical ventilation
Measure: Proportion of participants who are alive and free of invasive mechanical ventilation Time: Through Day 28Description: Time to all-cause mortality
Measure: All-cause mortality Time: Through Day 28